Seattle Genetics drug could provide new option for bladder cancer patients

Seattle Genetics drug could provide new option for bladder cancer patients

Source: 
Biopharma Dive
snippet: 

Tumors either got smaller or stopped growing in more than two-fifths of certain advanced urothelial cancer patients put on an experimental drug from Seattle Genetics, according to clinical trial data presented Monday at the American Society of Clinical Oncology's annual meeting.